Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma: A study of 51 cases from a low- endemicity area

Acta Oncologica

Volumn 37, Issue 1, 1998, Pages 77-83

  Kaczynski, Jerzy ^a   Hansson, Göran ^a   Wallerstedt, Sven ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER INCIDENCE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; SEX RATIO; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIARY TRACT; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; VEINS;

EID: 0031915524     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698423212     Document Type: Article

References (44)

1. Cook GC. Hepatocellular carcinoma: one of the world's most common malignancies. Q J Med 1985; 233: 705-8.
2. Bassendine MF. Aetiological factors in hepatocellular cancer. Baillières Clin Gastroenterol 1987; 1: 1-16.
3. Vitale GC, Heuser LS, Polk HC. Malignant tumors of the liver. Surg Clin North Am 1986; 66: 723-41.
4. Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract. In: MacSween RNM, Anthony PP, Scheuer PJ, eds. Pathology of the liver, 2nd edn. Edinburgh: Churchill Livingstone, 1987: 574-645.
5. Okuda K. Primary liver cancer. Dig Dis Sci 1986; 31: 133-46.
6. Colombo M. Hepatocellular carcinoma. J Hepatol 1992; 15: 225-36.
7. Okuda K, Kubo Y, Okazaki N, et al. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma. Cancer 1977; 39: 232-46.
8. Kawarada Y, Mizumoto R. Cholangiocellular carcinoma of the liver. Am J Surg 1984; 147: 354-9.
9. Yamanaka N, Okamoto E, Ando T, et al. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 1995; 76: 2449-56.
10. Ohashi K, Nakajima Y, Kanehiro H, et al. Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. Gastroenterology 1995; 109: 1612-7.
11. Altaee MY, Johnson PJ, Farrant JM, Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 1991; 69: 2051-5.
12. Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology 1994; 20: 33S-40.
13. Nakajima T, Kondo Y, Miyazaki M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 1988; 19: 1228-34.
14. Ervasti J. Primary carcinoma of the liver. Acta Chir Scand 1964; (Suppl 334).
15. Hey A, Rockelein G. Primary carcinoma of the liver in autopsy material. Fortschr Med 1985; 103: 238-42.
16. Hafström L. Primary liver cancer in Sweden. Ann Chir Gynaecol Suppl 1986; 200: 11-2.
17. The Cancer Registry. Cancer incidence in Sweden 1958-1979. Stockholm: National Board of Health and Welfare, 1960-1982.
18. Kaczynski J, Hansson G, Wallerstedt S. Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer 1996; 73: 128-32.
19. Kaczynski J, Wallerstedt S. Registration of liver cancer data - a study on the reliability of the Swedish Cancer Registry. Acta Oncol 1989; 28: 716-7.
20. Kaczynski J, Hansson G, Hermodsson S, Olsson R, Wallerstedt S. Minor role of hepatitis B and C virus infection in etiology of hepatocellular carcinoma in a low endemic area. Scand J Gastroenterol 1996; 31: 809-13.
21. Wight DGD. Other primary tumours. In: Wight DGD, ed. Atlas of liver pathology. Lancaster: MTP Press Limited, 1982: 176-81.
22. Kaczynski J, Hansson G, Wallerstedt S. Metastases in cases with hepatocellular carcinoma in relation to Clinicopathologic features of the tumour - an autopsy study from a low endemic area. Acta Oncol 1995; 34: 43-8.
23. Nørredam K. Primary carcinoma of the liver. Acta Pathol Microbiol Scand [A] 1979; 87: 227-36.
24. Johnson PJ. The clinical features and natural history of malignant liver tumours. Baillières Clin Gastroenterol 1987; 1: 17-34.
25. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Ann Surg 1990; 211: 277-87.
26. Popper H. Hepatic cancers in man: quantitative perspectives. Environ Res 1979; 19: 482-94.
27. Broomé U. Löfberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995; 22: 1404-8.
28. Mir-Madjlessi SH, Farmer RG, Sivak MV. Bile duct carcinoma in patients with ulcerative colitis. Dig Dis Sci 1987; 32: 145-54.
29. Choi PM, Nugent FW, Zelig MP, Munson JL, Schoetz DJ. Cholangiocarcinoma and Crohn's disease. Dig Dis Sci 1994; 39: 667-70.
30. Lefkowitch JH. The epidemiology and morphology of primary malignant liver tumours. Surg Clin North Am 1981; 61: 169-80.
31. Janower ML, Miettinen OS, Flynn MJ. Effects of long-term Thorotrast exposure. Radiology 1972; 103: 13-20.
32. Selinger M, Koff RS. Thorotrast and the liver: a reminder. Gastroenterology 1975; 68: 799-803.
33. Ito Y, Kojiro M, Nakashima T, Mori T. Pathomorphologic characteristics of 102 cases of Thorotrast-related hepatocellular carcinoma. Cholangiocarcinoma, and hepatic angiosarcoma. Cancer 1988; 62: 1153-62.
34. Ellis EF, Gordon PR, Gottlieb LS. Oral contraceptives and Cholangiocarcinoma. Lancet 1978; 1: 207.
35. Littlewood ER, Barrison IB, Murray-Lyon IM, Paradinas FJ. Cholangiocarcinoma and oral contraceptives. Lancet 1980; 1: 310-1.
36. Stromeyer FW, Smith DH, Ishak KG. Anabolic steroid therapy and intrahepatic Cholangiocarcinoma. Cancer 1979; 43: 440-3.
37. Parham DM, Paterson JR, Gunn A, Guthrie W. Cholangiocarcinoma in two siblings with emphysema and alpha-1-antitrypsin deficiency. Q J Med 1989; 264: 359-67.
38. Ekbom A, Hsieh C-C, Yuen J, et al. Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet 1993; 342: 1262-5.
39. Chen MF, Jan YY, Wang CS, Jeng LBB, Hwang TL, Chen SC. Intrahepatic stones associated with cholangiocarcinoma. Am J Gastroenterol 1989; 84: 391-5.
40. Karran S, Lane RHS, Townend I, de la Hunt M. Calculous disease and cholecystitis. In: Wright R, Millward-Sadler GH, Alberti KGMM, Karran S. eds. Liver and biliary disease. 2nd edn. London: Baillière Tindall, 1985: 1433-62.
41. Higgins GK. The epidemiology of primary carcinoma of the liver. In: Pack GT, Islami AH, eds. Tumors of the liver. Recent Results Cancer Res, vol. 26. Berlin: Springer-Verlag, 1970: 4-14.
42. Hamperl H. The classification of liver tumors. In: Pack GT, Islami AH, eds. Tumors of the liver. Recent Results Cancer Res, vol. 26. Berlin: Springer-Verlag, 1970: 4-14.
43. Terada T, Kida T, Nakanuma Y, Noguchi T. Extensive portal tumor thrombi with portal hypertension in an autopsy case of intrahepatic Cholangiocarcinoma. Am J Gastroenterol 1992; 87: 1513-8.
44. Berge T. The metastasis of carcinoma with special reference to the spleen. Acta Path Microbiol 1967; (Suppl) 200 (thesis).